Denmark -
Danish -
Lægemiddelstyrelsen (Danish Medicines Agency)
mometasone "sandoz" 50 mikrogram/dosis næsespray, suspension
sandoz a/s - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
Denmark -
Danish -
Lægemiddelstyrelsen (Danish Medicines Agency)
mometasone sandoz 50 mikrogram/dosis næsespray, suspension
orifarm a/s - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
Denmark -
Danish -
Lægemiddelstyrelsen (Danish Medicines Agency)
mometasone "actavis" 50 mikrogram/dosis næsespray, suspension
actavis group ptc ehf. - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
Denmark -
Danish -
Lægemiddelstyrelsen (Danish Medicines Agency)
mometasone "stada" 50 mikrogram/dosis næsespray, suspension
stada arzneimittel ag - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
Denmark -
Danish -
Lægemiddelstyrelsen (Danish Medicines Agency)
mometason "orifarm" 50 mikrogram/dosis næsespray, suspension
orifarm a/s - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
Denmark -
Danish -
Lægemiddelstyrelsen (Danish Medicines Agency)
mometasonfuroat "teva" 50 mikrogram/dosis næsespray, suspension
teva b.v. - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
Denmark -
Danish -
Lægemiddelstyrelsen (Danish Medicines Agency)
mometason "orion" 50 mikrogram/dosis næsespray, suspension
orion corporation - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
Denmark -
Danish -
Lægemiddelstyrelsen (Danish Medicines Agency)
mometasonfuroat "zentiva" 50 mikrogram/dosis næsespray, suspension
zentiva k.s. - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
European Union -
Danish -
EMA (European Medicines Agency)
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - medicin for obstruktiv sygdomme, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
European Union -
Danish -
EMA (European Medicines Agency)
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - medicin for obstruktiv sygdomme, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.